In our study, we delved into the effects of ACTN1 overexpression on GSK-3β, revealing that ACTN1 negatively impacts GSK-3β stability in HNSCC cells and expedites its degradation via the ubiquitin–proteasome pathway. This evidence concerns the gene ACTN1 and head and neck squamous cell carcinoma.